PCNA and colonic neoplasm: This strategy was sufficient to diminish the number of colon tumors and was concomitant with reduction of inflammatory cytokines, IGF-1, and cell proliferation, the latter assessed via immunohistochemistry for proliferating cell nuclear antigen (PCNA) [186].